THYMOSIN ALPHA-1 3 MG

Thymosin Alpha-1 3 mg – Immune Support Peptide for Research | Peptide Hubs

Thymosin Alpha-1 (Tα1) is a synthetic peptide derived from the prothymosin alpha protein. This 3 mg vial by Peptide Hubs offers a research-grade formulation designed for laboratory studies exploring immune modulation, antiviral activity, and T-cell function. Thymosin Alpha-1 is not approved for human use and is sold for research purposes only.

What Is Thymosin Alpha-1?

Thymosin Alpha-1 is a 28-amino acid peptide shown to modulate immune responses by stimulating T lymphocytes and natural killer (NK) cells. Its immunoregulatory potential has made it a subject of intense research in viral defense, cancer immunology, and autoimmune disorder models. According to published studies, Thymosin Alpha-1 may help regulate immune response and inflammation through toll-like receptor activation and modulation of cytokine release.

Key Research Benefits of Thymosin Alpha-1

• Promotes T-cell differentiation and immune activation
• May enhance resistance to viral and bacterial infections
• Studied in models of chronic inflammation and cancer
• Supports immunological balance in aging research
• Non-toxic, non-hormonal profile for preclinical applications

Suggested Dosage Protocol in Research

In most preclinical studies, researchers use Thymosin Alpha-1 at dosages of 1–3 mg per week, typically administered subcutaneously. The peptide has a relatively short half-life (~2 hours), making multiple low-dose administrations common depending on the duration of the study (e.g., 2–4 weeks).

Stacking Suggestions

Thymosin Alpha-1 is often stacked with other immune-regulating or regenerative peptides for comprehensive system support:

• Thymalin – for thymic regeneration and T-cell development
• Selank – for neuroimmune balance and cognitive focus
• AOD 9604 – supports metabolic health and immune-linked fat metabolism
• BPC-157 – promotes healing in tissues and gut mucosa
• SS-31 – for mitochondrial protection and cellular repair

Safety and Laboratory Observations

Thymosin Alpha-1 has demonstrated a strong safety profile in animal models and early-phase human trials. It does not interact with hormonal systems and poses no liver or kidney toxicity. Injection site reactions may occur but are generally mild and transient. It is not approved by the FDA for clinical use and is designated for research purposes only.

USA Domestic Shipping and Product Quality

All Peptide Hubs products, including Thymosin Alpha-1 3 mg, are eligible for USA domestic shipping with fast, discreet delivery. Each vial is manufactured in GMP-compliant labs and tested for purity. Consider pairing with GHK-Cu or CJC-1295 DAC for systemic immune and regenerative research protocols.

Frequently Asked Questions